Literature DB >> 16860883

Quantitation of encapsidated recombinant adeno-associated virus DNA in crude cell lysates and tissue culture medium by quantitative, real-time PCR.

John P Mayginnes1, Sharon E Reed, Heath G Berg, Elizabeth M Staley, David J Pintel, Gregory E Tullis.   

Abstract

Recombinant AAV vectors are produced by transient transfection of mammalian cells. The virus is usually purified from a combination of lysed cells and spent culture medium by HPLC. We have developed a quantitative, real-time PCR assay for quantifying encapsidated single-stranded viral DNA (i.e. DNA-containing virions) in cell lysates and the spent culture medium. This requires extensive DNaseI digestion to reduce the amount of AAV replicative DNA, as well as plasmid and cellular DNA, to negligible amounts. To demonstrate the utility of this assay, we produced recombinant AAV in HeLa cells and five different types of 293 cells. We used primers to the EGFP transgene to detect the production of a recombinant AAV. We assayed the cell lysates and media by both our quantitative PCR assay and a functional transduction assay. The quantitative PCR assay data correlated well with the transduction assay data. Because this assay only requires standard PCR primers and SYBR Green I dye to detect the amplification of the PCR template, it will readily adapt to any target DNA sequence within the recombinant AAV genome. The recombinant AAV vector does not need to express a reporter gene, such as EGFP or beta-galactosidase in order to assay the amount of virus produced.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860883     DOI: 10.1016/j.jviromet.2006.06.011

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  18 in total

1.  Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons.

Authors:  Matthew R J Mason; Erich M E Ehlert; Ruben Eggers; Chris W Pool; Stephan Hermening; Angelina Huseinovic; Eric Timmermans; Bas Blits; Joost Verhaagen
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

2.  Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1-9 and lentiviral vectors.

Authors:  S A Hoyng; F De Winter; S Gnavi; L van Egmond; C L Attwell; M R Tannemaat; J Verhaagen; M J A Malessy
Journal:  Gene Ther       Date:  2015-05-04       Impact factor: 5.250

3.  Improved splicing of adeno-associated viral (AAV) capsid protein-supplying pre-mRNAs leads to increased recombinant AAV vector production.

Authors:  K David Farris; David J Pintel
Journal:  Hum Gene Ther       Date:  2008-12       Impact factor: 5.695

4.  A Scalable and Accurate Method for Quantifying Vector Genomes of Recombinant Adeno-Associated Viruses in Crude Lysate.

Authors:  Jianzhong Ai; Raed Ibraheim; Phillip W L Tai; Guangping Gao
Journal:  Hum Gene Ther Methods       Date:  2017-04-13       Impact factor: 2.396

5.  AAV9-DOK7 gene therapy reduces disease severity in Smn2B/- SMA model mice.

Authors:  Kevin A Kaifer; Eric Villalón; Caley E Smith; Madeline E Simon; Jose Marquez; Abigail E Hopkins; Toni I Morcos; Christian L Lorson
Journal:  Biochem Biophys Res Commun       Date:  2020-07-30       Impact factor: 3.575

6.  Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy.

Authors:  Kevin A Kaifer; Eric Villalón; Erkan Y Osman; Jacqueline J Glascock; Laura L Arnold; D D W Cornelison; Christian L Lorson
Journal:  JCI Insight       Date:  2017-03-09

7.  A pseudo-plaque method for infectious particle assay and clonal isolation of adeno-associated virus.

Authors:  Daniel A J Mitchell; Thomas F Lerch; Joan T Hare; Michael S Chapman
Journal:  J Virol Methods       Date:  2010-08-11       Impact factor: 2.014

8.  AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B/-SMA model mice.

Authors:  Kevin A Kaifer; Eric Villalón; Benjamin S O'Brien; Samantha L Sison; Caley E Smith; Madeline E Simon; Jose Marquez; Siri O'Day; Abigail E Hopkins; Rachel Neff; Hansjörg Rindt; Allison D Ebert; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

9.  Directed evolution of adeno-associated virus for glioma cell transduction.

Authors:  Casey A Maguire; Davide Gianni; Dimphna H Meijer; Lev A Shaket; Hiroaki Wakimoto; Samuel D Rabkin; Guangping Gao; Miguel Sena-Esteves
Journal:  J Neurooncol       Date:  2009-07-19       Impact factor: 4.130

10.  Detection of calcium transients in embryonic stem cells and their differentiated progeny.

Authors:  Jason S Meyer; Gregory Tullis; Christopher Pierret; Kathleen M Spears; Jason A Morrison; Mark D Kirk
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.